［1］Siegel RL，Miller KD，Jemal A.Cancer statistics，2015［J］.CA Cancer J Clin，2015，65(1)：5-29.
［2］Salani R，Bristow RE.Surgical management of epithelial ovarian cancer［J］.Clin Obstet Gynecol，2012，55(1)：75-95.
［3］Moss EL，Hollingworth J，Reynolds TM.The role of CA125 in clinical practice［J］.J Clin Pathol，2005，58(3)：308-312.
［4］Friedman RC，Farh KK，Burge CB，et al.Most mammalian mRNAs are conserved targets of microRNAs［J］.Genome Res，2009，19(1)：92-105.
［5］Bartel DP.MicroRNAs：target recognition and regulatory functions［J］.Cell，2009，136(2)：215-233.
［6］Ebert MS，Sharp PA.Roles for microRNAs in conferring robustness to biological processes［J］.Cell，2012，149(3)：515-524.
［7］Hata A，Kashima R.Dysregulation of microRNA biogenesis machinery in cancer［J］.Crit Rev Biochem Mol Biol，2016，51(3)：121-134.
［8］Zhang S，Lu Z，Unruh AK，et al.Clinically relevant microRNAs in ovarian cancer［J］.Mol Cancer Res，2015，13(3)：393-401.
［9］Xu CX，Xu M，Tan L，et al.MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog［J］.J Biol Chem，2012，287(42)：34970-34978.
［10］Katz B，Trope CG，Reich R，et al.MicroRNAs in ovarian cancer［J］.Hum Pathol，2015，46(9)：1245-1256.
［11］Weber JA，Baxter DH，Zhang S，et al.The microRNA spectrum in 12 body fluids［J］.Clin Chem，2010，56(11)：1733-1741.
［12］Nakamura K，Sawada K，Yoshimura A，et al.Clinical relevance of circulating cell-free microRNAs in ovarian cancer［J］.Mol Cancer，2016，15(1)：48.
［13］Taylor DD，Gercel-Taylor C.MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer［J］.Gynecol Oncol，2008，110(1)：13-21.
［14］Resnick KE，Alder H，Hagan JP，et al.The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform［J］.Gynecol Oncol，2009，112(1)：55-59.
［15］Kanaan Z，Roberts H，Eichenberger MR，et al.A plasma microRNA panel for detection of colorectal adenomas：a step toward more precise screening for colorectal cancer［J］.Ann Surg，2013，258(3)：400-408.
［16］Qi ML，Zhao YY，Fei X.Expression and role of miR-17-5p in bladder cancer cell lines［J］.Modern Oncology，2013，21(06)：1177-1180.［齐漫龙，赵彦艳，费翔.miR-17-5p在膀胱癌细胞中的表达和功能［J］.现代肿瘤医学，2013，21(06)：1177-1180.］
［17］Yang B，Jing C，Wang J，et al.Identification of microRNAs associated with lymphangiogenesis in human gastric cancer［J］.Clin Transl Oncol，2014，16(4)：374-379.
［18］Shan SW，Fang L，Shatseva T，et al.Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN，GalNT7 and vimentin in different signal pathways［J］.J Cell Sci，2013，126(Pt 6)：1517-1530.
［19］Lu S，Wang S，Geng S，et al.Increased expression of microRNA-17 predicts poor prognosis in human glioma［J］.J Biomed Biotechnol，2012，2012：970761.
［20］Chen Q，Si Q，Xiao S，et al.Prognostic significance of serum miR-17-5p in lung cancer［J］.Med Oncol，2013，30(1)：353.
［21］Wang M，Gu H，Wang S，et al.Circulating miR-17-5p and miR-20a：molecular markers for gastric cancer［J］.Mol Med Rep，2012，5(6)：1514-1520.
［22］Que R，Ding G，Chen J，et al.Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma［J］.World J Surg Oncol，2013，11：219.
［23］Oksuz Z，Serin MS，Kaplan E，et al.Serum microRNAs,miR-30c-5p，miR-223-3p，miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma［J］.Mol Biol Rep，2015，42 (3)：713-720.
［24］Zheng J，Dong P，Gao S，et al.High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma［J］.Hepatogastroenterology，2013，60(123)：549-552.
［25］Hossain A，Kuo MT，Saunders GF.miR-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA［J］.Mol Cell Biol，2006，26(21)：8191-8201.
［26］Matsubara H，Takeuchi T，Nishikawa E，et al.Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92［J］.Oncogene，2007，26(41)：6099-6105.
［27］Volinia S，Calin GA，Liu CG，et al.A microRNA expression signature of human solid tumors defines cancer gene targets［J］.Proc Natl Acad Sci USA，2006，103(7)：2257-2261.
［28］Fontana L，Fiori ME，Albini S，et al.Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM［J］.PLoS One，2008，3(5)：e2236.
［29］Sarhan RA，Aboelenein HR，Sourour SK，et al.Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients［J］.Discov Med，2015，19(107)：419-425.
［30］Li L，He L，Zhao JL，et al.MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines［J］.J Cell Biochem，2015，116(6)：1050-1059.